The CML-associated p40ABL/BCR, in contrast to p96ABL/BCR, also reduced the expression of BLNK and CD79a, whereas neither of these proteins influenced the expression of CD19. This evidence concerns the gene CD19 and chronic myelogenous leukemia, BCR-ABL1 positive.